159 related articles for article (PubMed ID: 14509150)
1. Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel.
Feldman PA; Steinberg J; Madeb R; Bar G; Nativ O; Tal J; Srugo I
Isr Med Assoc J; 2003 Sep; 5(9):626-8. PubMed ID: 14509150
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence and determinants of herpes simplex type 2 infection in an STD clinic in Milan, Italy.
Suligoi B; Calistri A; Cusini M; Palù G;
J Med Virol; 2002 Jul; 67(3):345-8. PubMed ID: 12116025
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics.
Gottlieb SL; Douglas JM; Schmid DS; Bolan G; Iatesta M; Malotte CK; Zenilman J; Foster M; Barón AE; Steiner JF; Peterman TA; Kamb ML;
J Infect Dis; 2002 Nov; 186(10):1381-9. PubMed ID: 12404152
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type 2 infection of heterosexual men attending a sexual health centre.
Bassett I; Donovan B; Bodsworth NJ; Field PR; Ho DW; Jeansson S; Cunningham AL
Med J Aust; 1994 Jun; 160(11):697-700. PubMed ID: 8202004
[TBL] [Abstract][Full Text] [Related]
5. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus.
Slomka MJ
Commun Dis Rep CDR Rev; 1996 Mar; 6(3):R41-5. PubMed ID: 8820192
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors for herpes simplex virus type 2 infection among pregnant women in Israel.
Dan M; Sadan O; Glezerman M; Raveh D; Samra Z
Sex Transm Dis; 2003 Nov; 30(11):835-8. PubMed ID: 14603091
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of genital herpes infections.
Mertz GJ
Infect Dis Clin North Am; 1993 Dec; 7(4):825-39. PubMed ID: 8106731
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of herpes simplex virus type 2 among STD clinic attenders in Delhi, India.
Kaur R; Mittal N; Bhalla P; Reddy BN; Baveja UK
J Commun Dis; 2006 Dec; 38(4):339-43. PubMed ID: 17913210
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of herpes simplex virus type 2 antibodies in New Zealand sexual health clinic patients.
Perkins NL; Coughlan EP; Franklin RA; Reid MR; Taylor J
N Z Med J; 1996 Oct; 109(1032):402-5. PubMed ID: 8937391
[TBL] [Abstract][Full Text] [Related]
10. [Seroprevalence of type 2 herpes simplex virus infection in 3 population groups of Mexico City].
Conde-González CJ; Lazcano-Ponce E; Hernández-Girón C; Juárez-Figueroa L; Smith JS; Hernández-Avila M
Salud Publica Mex; 2003; 45 Supp 5():S608-16. PubMed ID: 14974271
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention.
Lafferty WE; Downey L; Celum C; Wald A
J Infect Dis; 2000 Apr; 181(4):1454-7. PubMed ID: 10762576
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence and correlates of herpes simplex virus type-2 infection in a general gynecology clinic.
Maitra N; Gupta M
Arch Gynecol Obstet; 2007 Jan; 275(1):19-23. PubMed ID: 16868756
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers.
McFarland W; Gwanzura L; Bassett MT; Machekano R; Latif AS; Ley C; Parsonnet J; Burke RL; Katzenstein D
J Infect Dis; 1999 Nov; 180(5):1459-65. PubMed ID: 10515804
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of herpes simplex virus type 2 antibodies in an STD clinic in Paris.
Janier M; Lassau F; Bloch J; Spindler E; Morel P; Gérard P; Aufrère A
Int J STD AIDS; 1999 Aug; 10(8):522-6. PubMed ID: 10471101
[TBL] [Abstract][Full Text] [Related]
15. The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia.
Uusküla A; Nygard-Kibur M; Cowan FM; Mayaud P; French RS; Robinson JN; Brown DW
Scand J Infect Dis; 2004; 36(10):727-32. PubMed ID: 15513398
[TBL] [Abstract][Full Text] [Related]
16. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling.
Gottlieb SL; Douglas JM; Foster M; Schmid DS; Newman DR; Baron AE; Bolan G; Iatesta M; Malotte CK; Zenilman J; Fishbein M; Peterman TA; Kamb ML;
J Infect Dis; 2004 Sep; 190(6):1059-67. PubMed ID: 15319854
[TBL] [Abstract][Full Text] [Related]
17. Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study.
Jonsson MK; Levi M; Rudén U; Wahren B
Scand J Infect Dis; 2006; 38(5):357-65. PubMed ID: 16709538
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic.
Gallo MF; Warner L; Macaluso M; Stone KM; Brill I; Fleenor ME; Hook EW; Austin HD; Lee FK; Nahmias AJ
Sex Transm Dis; 2008 Jul; 35(7):679-85. PubMed ID: 18461012
[TBL] [Abstract][Full Text] [Related]
19. Importance of herpes simplex virus type-1 (HSV-1) in primary genital herpes.
Nieuwenhuis RF; van Doornum GJ; Mulder PG; Neumann HA; van der Meijden WI
Acta Derm Venereol; 2006; 86(2):129-34. PubMed ID: 16648915
[TBL] [Abstract][Full Text] [Related]
20. A seroprevalence study of herpes virus type 2 infection in Israeli women: implications for routine screening.
Isacsohn M; Bar On E; Yaeger Y; Smetana Z; Weiner D; Slater PE
Isr J Med Sci; 1994; 30(5-6):379-83. PubMed ID: 8034487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
